No increase in walking distance on repeated tests in COPD patients with exercise-induced hypoxaemia

Authors: Arnardóttir, Ragnheiður Harpa1; Sörensen, Stefan2; Ringqvist, Ivar3; Larsson, Kjell4

Source: Advances in Physiotherapy, Volume 9, Number 4, 2007 , pp. 161-168(8)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $33.00 plus tax (Refund Policy)

Abstract:

The aim of the study was to investigate the effect of retesting on the 12-min walking distance (12MWD) in patients with moderate or severe chronic obstructive pulmonary disease (COPD), with and without exercise-induced hypoxaemia (EIH) and to evaluate whether baseline characteristics derived before walking influence on variation of repeated tests. Fifty-seven COPD patients, mean age 66 (range 47 84) years, performed three 12-min walk tests within 1 week. Before and after each test, oxygen saturation (pulse oximetry, SpO2), heart rate, breathing frequency, peak expiratory flow, and subjective ratings of exertion and dyspnoea were measured. EIH was defined as a fall in SpO2 below 90% at the first walk test. The 12MWD did not increase on repeated testing in the EIH group. In the non-EIH group, the 12MWD increased by 12% (p<0.001) from test 1 to test 2 and by 4% (p<0.001) from test 2 to test 3. No day-to-day variation was observed in pre-walking characteristics. At least one training test is needed in non-EIH patients with COPD, as their effort and performance on the 12-min walk test increases on retesting (learning effects). In patients with EIH, the term "training test" is not relevant, as their walking distance did not homogeneously increase on repeated testing.

Keywords: 12-min walk test; chronic obstructive pulmonary disease; exercise testing; exercise-induced hypoxaemia; pulse oximetry; retest effects; walk tests

Document Type: Research article

DOI: http://dx.doi.org/10.1080/14038190701532844

Affiliations: 1: Department of Medical Sciences: Respiratory Medicine and Allergology, Uppsala University, Uppsala, Sweden 2: Mälardalen University, Västerås, Sweden 3: Center for Clinical Research, Central Hospital, Västerås, Sweden 4: Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Publication date: 2007-01-01

More about this publication?

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page